Skip to content

Ultrasound-guided Intercostal Pleural Surface Block in Video-Assisted Thoracoscopic Surgery

Ultrasound-guided Intercostal Pleural Surface Block in Video-Assisted Thoracoscopic Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500113847
Enrollment
Unknown
Registered
2025-12-03
Start date
2025-12-08
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Video-Assisted Thoracoscopic Surgery

Interventions

Observation Group:None

Sponsors

The Affiated Cancer Hospital of Guizhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients scheduled for elective thoracoscopic unilateral lobectomy or wedge resection of the lung; 2. Gender is not limited, age 45 to 65 years old; 3. ASA grade I to III, 18.5 <= BMI <= 27 kg/m^²;

Exclusion criteria

Exclusion criteria: 1 Infection at the puncture site; 2 Anaphylaxis to local anesthetic; 3 Long-term use of opioid drugs; 4 Severe cardiovascular and cerebrovascular diseases (such as NYHA classification >= III grade or LVEF = 160/100 mmHg); acute coronary syndrome or stroke occurred within 6 months); 5 Abnormal liver and kidney functions (ALT/AST > 2 times upper limit, eGFR 7.5%); 7 Abnormal coagulation function (INR > 1.5 or PLT < 80×10^9/L).

Design outcomes

Primary

MeasureTime frame
first-attempt rate;overall block success rate;ultrasound-guided procedure time;operator-rated difficulty on a numerical rating scale (NRS);block-related complications;Methylene blue staining area;

Secondary

MeasureTime frame
The NRS pain scores at rest and during coughing at 2 hours, 24 hours and 48 hours after the operation; number of effective PCA presses and use of rescue analgesics at 2, 24, and 48 hours postoperatively;the amount of opioid drugs used during the operation;incidence of hypertension/hypotension ;the use of vasoactive drugs;

Countries

None

Contacts

Public ContactWan Qing

The Affiated Cancer Hospital of Guizhou Medical University

34219463@qq.com+86 189 8438 5627

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026